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veRt~ic~ia~ function, coronary angioplasty is being increas- 
to patients at higher isk. pite substantial 
provements, a~~~o~i~ate~y of patients un- 
dergoi~g coronary angio asty experience acute vessel do- 
sure (I). This complicat anaged with emer- 
gent bypass urgery, which d with a mortality 
rate of about 7% (2.3). Patients at high risk for the develop- 
odynamic collapse after acute vessel closure are 
usually not considered appropriate angioplasty candidaw 
because they may rot survive long enough to undergo 
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surgery. Such patients generally have poor left _ . . . 
undergo the procedure, and institutional Revi 
approval was obtained in all centers conside~~g 
dure investigational. 
rd 
e- ventricular function or a target vessel supplying substanttaf 
amounts of myocardium, orboth. They may also experience 
hemodynamic collapse during balloon inflation. Angioplasty 
performed in these high risk patients has been accomplished 
using prophylactic intraaortic bakoon pumping (4.5) or car- 
diopulmonary b pass in the operating room in association 
with bypass urgery (6). 
In an effort o reduce the potential hemodynamic prob- 
lems associated with high risk angioplasty, we began to place 
angioplasty patients prophylactically on cardiopulmonary 
bypass in December 1987 (7-9). We have termed this tech- 
nique “supported angioplasty.” Cardiopulmonary support 
has been accomplished using a portable, centrifugal pump- 
membrane oxygenator system (C.R. Bard, Inc.) that pro- 
vides up to 6 Iiterslmin output using percutaneous or cut- 
down femoral vein and artery cannulation. In March 1988 
after initial success with the procedure, six centers agreed to 
form a National Registry of elective supported angioplasty o
document the initial multicenter xperience with the proce- 
dure. Our results as well as those from eight additional 
centers joining the Registry are presented inthis report. 
Participating institutions. After the initial formation of 
the Registry by 6 medical centerr, an additional I1 medical 
centers known to be performing supported angioplasty were 
contacted with regard to participation in the Registry. Eight 
of these institutions agreed to participate. The 14 principal 
interventionalists and institutions participating in the Regis- 
try are listed in the Appendix. It was prospectively agreed 
that he data from all patients undergoing elective supported 
angiopiasty through December 31, 1988 would constitute he 
initial report. 
Inclusion criteria. For inclusion in the Registry, elective 
supported angioplasty was defined as prophylactic use of 
femorofemoral c rdiopulmonary support in patients under- 
going coronary intervention i  the catheterization laboratory 
who were hemodynamically stable at the start of the proce- 
dure. Patients with unstable hemodynamics were considered 
emergent and were excluded from the Registry. Suggested 
indications for inclusion were: 1) the presence of severe or 
unstable angina pectoris, 2) at least one likely dilatable 
coronary artery stenosis, and 3) left ventricular ejection 
fraction <25% or a target vessel supplying more than half of 
the viable myocardium, or both. Left ventricular ejection 
fraction was determined from right anterior oblique !eft 
ventriculography or radionuclide angiography. An arteq 
suppbing more than half of the viable myocardium was 
defined by either provision of collateral flow to R total!) 
mhded major vessel or as the more widely distributing 
vessel in the presence of a totally occluded, noncollateral- 
ized major vessel. AU patients gave informed consent o 
data. Data forms were completed at the end of 
the alization, during which tke supported angioplasty 
was performed, and follow-up evaluation was requested in
November 1988. Demographic data included patient identi- 
fication, age and gender. Clinical data included New York 
Heart Association classification f chest pain and congestive 
heart failure status, angiographic extent and severity of 
coronary artery disease, left ventricular ejection fraction, 
performance of associa ~~te~ve~~io~a~ procedures and 
classification of the inte ntion as a substitute for unsup 
ported or intraaortic balloon pump-supported angioplasty or
coronary artery bypass urgery. Patients were classified as 
surgically operable or inoperable on the basis of local clinical 
practice. 
Cardiopulmonary support data includtid method of can- 
nula insertion artd pump flow and duration. Coronary angio- 
plasty data included femoral or brachial approach, location 
of coronary artery stenoses undergoing attempted dilation, 
angiographic appearance of the coronary stenosis after dila- 
tion and transstenotic pressure gradient before and after 
dilation. Successful angioplasty was defined as an interven- 
tion resulting in >20% reduction in relative diameter vessel 
narrowing, with residual narrowing of <50%. The occur- 
rence of chest pain or electocardiographic (ECG) changes 
suggesting coronary isc emia during balloon inflation was 
noted. Hospitalization ata included late vessel closure, 
need for additional surgical intervention or blood transfu- 
sion, morbidity and mortality. Follow-up data included chest 
pain classification at follow-up study, need for post- 
hospitalization surgical procedure and mortality. 
Technique. Procedures were performed in the catheter- 
ization laboratory under local anesthesia and mild sedation. 
The operation of the cardiopulmonary support system was 
generally directed by a perfusionist. Arterial blood pressure 
and blood gases, pulmonary artery wedge pressure, ECG, 
blood coagulation variables and electrolytes were moni- 
tored. Femoral cannula insertion was performed using either 
local cutdown and direct vessel puncture or the percutane- 
ous insertion technique described by §hawl et al. (10). 
Cardiopulmonary b pass was instituted before coronary 
artery instrumentatioa. Because of the 18 to 2gF diameter of 
cannulas employed, the size, level of bifurcalion and pres- 
ence of vessel stenosis of the femoral artery employed for 
bypass were determined before insertion by iliac angiogra- 
phy. For percutaneous in ertion, progressive ssel dilation 
was undertaken before cannula insertion. Under Wuoro- 
scopic guidance, the multiple side-holed 18 to 20F venous 
and arterial cannulas were positioned at the junction of the 
right atrium and inferior vena cava and iliac artery, respec- 
fiv~?ly. Heparin was administered in a 300 unit/kg dose before 
cannula insertion, and premeditation with aspirin, nitroglyc- 
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NO. 
Chest pain (NYHA class) 
II 
111 
IV 
CHF (NYHA class) 
I 
II 
III 
IQ 
Coronary stenosis (>50% diameter) 
LMCA 
LAD 
LCX 
RCA 
5 
6 
26 
66 
56 
9 
19 
18 
17 
93 
82 
34 
LQEF ~25% LVEF ~25% 
achieve bemostaas. 
Target vessel supplies 
All myocardium 
rS myocardium 
<ti myocardium 
F = congestive heart failure: LAD = left r descendkg coroclnary 
artery; LCx = left circumflex coronary artery: = left main coronary 
artery: LVEF = kft ventricular ejection fraction; NYHA class = New York 
Heart Association class; RCA = right coronary artery. 
n fraction between 25% 
ort was estab~isbed 
cutdown in 4,f. The 
tic valvuloplssty and left main catheter atherectomy were complexity than to number of vessels with attempted dila- 
performed in association with supposed coronary angio- tion. In three patients, cannulas were inserted but cardiopul- 
plasty in one patient each. monary support was not initiated. 
Clinical and angiographic characteristics of the patients 
are listed in Table 1. Of the 105 patients, 92 had class III or 
IV angina, including unstable angina, before the procedure. 
Angiographic one, two and three vessel disease (>50% 
diameter narrowing) was present in 8, 32 and 65 patients, 
respectively. I,e.ft main carl9nary artery stefiosis was present 
in 1’7 patients, and 30 had only one patent vessel, including 
bypass grafts. The mean ection fraction of the group was 
32% (range 6% to 47%). 35 patients the ejection fraction 
was <25%, in 23 it was (20% and in 4 it was ~10%. Twelve 
patients had both an’terior and inferior Q wave myocardia~ 
infarction. 
Coronary angiop!asty was performed by the femoral 
route in 100 patients. Successful balloon dilation was 
achieved in 173 (95%) of 182 vessels with attempted dilation; 
individual rtery success rates are listed in Table, !. By visual 
interpretation, the mean diameter stenosis was l::duLed from 
90% to 25% and the mean translesional gradient from 49 to 9 
mm Hg (on cardiopulmonary bypass) in those vessels under- 
going soccessful dilation. Of the 17 patients with left main 
coronary artery stenosis, 15 ~~de~e~t dilation of that 
vessel; the outcome was considered successful im 13. Over- 
aPI, 1.7 vessels per patient were dilate 
Ninety patieuts met t e suggested ~~c~~sio~ criteria of 
ejection fraction ~25% (35 patients) or target vessel supply- 
ing more than half the viable myocardium (74 patienrs), or 
both (19 patients), The majority of the 15 patients not 
dilations in patients with only one patent vessel are as 
follows: left main = 4, left anterior descending = 8, left 
circumflex = ;3, right = 1, left anterior descending bypass 
graft = 3 and right bypass graft = 1. Forty patients had 
complete reva&arization, defined as successful dilation of 
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Table 2. Results of Coronary Angioplasty in 105 Patients 
Successful Dilations/ 
Lesions Attempted 
LMCA 
LAD 
LCX 
RCA 
LAD bypass graft 
LAD internal mammary artery graft 
LCx bypass graft 
Right bypass graft 
Abbreviations as in Table I. 
13/15 
61/63 
53156 
34136 
616 
l/I 
212 
313 
all vessels with >SO% stenosis. Chest pain and ECG changes 
suggesting ischemia occurred uring balloon inflation in, 
respectively, 22% and 23% of the patients. 
Morbidity (Table 3). Postangioplasty vessel closure with- 
out symptomatic prodrome occurred in 7 of 173 successful 
dilations at 10 h to 4 dajs after intervention. Of the seven 
patients experiencing this complication, four died during 
hospitalization. Anadditional surgical procedure other than 
elective vessel closure was required uring hospitalization in 
12 patients: repair of the femoral artery (including pseudo- 
aneurysm) in 7, coronary artery bypass urgery in 4 and 
laparotomy for bowel infarction in 1. Blood loss requiring 
transfusion occurred in 45 patients (43%), approximately 
equally divided between those undergoing cutdown and per- 
Table 3. Patient Morbidity in105 Patients 
Incidence 
Vessel catmutation 
Femoral artery repair (required) 4 
Femoral artery occlusion 1 
Fenoral rtery pseudoaneurysm 3 
Large hematoma 4 
Thrombophlebitis 5 
Cannula site infection/necrosis 8 
Femoral nerve injury (transient) 2 
Embolism 
Superior mesenteric artery emboluslthrombus I 
Cerebrovascular accident I 
Transient cerebral ischemia I 
Angioplasty 
LV dysfunction requiring balloon pump 1 
Post-PTCA myocardial ischemia 5 
PEWTCA myowdial infarction 
Cardiac arrest I 
Other 
Gastrointestinal bleeding 2 
Diabetic ketoacidosis (bowel is&e&j I 
Acute renal failure I 
Lv = left venkicular; PICA = percutaneous transluminal coronary 
angioplasty. 
cutaneous cannula insertion. A mean of 3.7 units of blood 
(range 1 to 12) were administered in patients re 
fusion. 
Complications were frequent. Forty-eight CO 
other than need for transfusion occurred in 
(Table 3). The majority (52%) of these complications in- 
volved arterial, venous or nerve injury at the cannulation 
site, including those caused by prolonged clamping. No 
significant differences were noted in patients 
cutdown or percutaneous cannula i 
Two systemic emboli occurre 
middle cerebral rteries); the latter 
excessive guiding catheter manipulati 
rienced transient cerebral ischemia. No other direct corn- 
plications of cardiopulmonary b pass were encountered. 
Significant hemolysis and thrombocytopenia were not 
experienced. Four patients required immediate bypass 
surgery, three because of acute vessel closure and one 
because of unsuccessful di ation. Patients were transported 
to the operating room on cardiopulmonary support in all 
cases. 
ortality. None of the patients were found to 
pulmonary support-dependent after angioplasty, although 1
of the 105 required temporary intraaortic balloon pump 
assistance; this patient had a successful outcome. Eight 
patients (7.6%) died during hospitalization, from 2 h to 7 
days after the procedure. Four died after coronary artery 
occlusion, and one each of abdomind hemorrhage, mesen- 
teric artery thrombosis, femoral artery thrombosis and dur- 
ing bypass urgery. The association ofolder age (~75 years) 
with left main coronary artery stenosis was present in four of 
the eight patients who died. The presence of either of these 
two risk factors alone was associated with an 8% hospital 
mortality rate. Concurrence of the two risk factors was 
associated with an 80% (four of five) mortality rate. Only 2 
(2.6%) of the 76 patients died who had neither of these risk 
factors. Table 4 demonstrates that patients in several high 
risk categories did well with supported angioplasty. Patients 
undergoing dilation of their only patent coronary vessel, 
those deemed inoperable and those with an ejection fraction 
520% had a hospital mortality rate of 7%, 0% and 4%, 
respectively. 
FoMow-up. Registry patients were followed up for 1 to 12 
months after hospital discharge. Seventy-six patients (72%) 
were experiencing class I or II angina t follow-up; 91% of 
the patients had improvement by at least two classes. An 
additional surgical procedure during subsequent hospitaliza- 
tion was required in seven patients (four angioplasty [on 
intraaortic balloon pump], two bypass surgery and one 
cardiac transplantation). Four patients died during the fol- 
low-up period, one each from the following causes: conges- 
tive heart failure, myocardial infarction, suicide and elective 
hernia surgery. 
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Table ortaiity in 105 Patients: S&group Analysis 
~. 
PTCA Only Age <Pi yr. 
LIWM Patent CABG LVEF No Stenosis 
Age =75 yr stenosis Vessel lnop G!Q% LMCA 
No. 17 17 30 20 23 76 
LVEF 35% 45% 21% 28% 16% 28% 
Mortality 5* (29%) 5” (29%) 2 (7%) U Ul%) 1 14%) 2 (2.6%) 
*Four patients 275 years ok! also had Deft main coronary artery stenosis: the mortality rate of patients either 275 years old or with left main stenosis alone 
was 8%. CA.BC = coronary artery bypass surgery: lnop = inoperable: other abbreviations a in Tables 1 and 3. 
ence a warm sensation 
myocardial dysfu~ct 
finding, only 20% to 
between absence of c 
ischemia is not well defi 
ported that chest paira occurrrng during balloon 
Other currently available systemic and coromry circula- 
tory support apprwches include intraaortic balloon pumping 
(4,5), traansaortic valve turbine pumping (12), percutaneous 
left ventricular assist (13), passive and active coronary sinus 
retro~e~~s~o~ (14-16) ~2nd pas ive or active bako 
coronary perfusion (17-19). ntraaortic balloon 
(4,5) augments cardiac outpct Otliy 20% to 30% a 
value in the presence 5f se re arrhythmias. Recently. 
transaortic tnrbke pumping s been used for elective 
supported angioplasty. Although this system cannot yet be 
placed percutaneously, it may be used for more prolon;ged 
periods of time compared with the 6 to 12 h possible using 
femoral cardiopulmonary b pass. Percutaneous Ileft ventric- 
assivc perfttsisn, but myocardial protection is 
a much lesser extent han wirk relrQ~~mpi~~ 
nary artery distr~b~t~ons. None of t 
niques provides ystemic support, however, and about 20% 
nuses cannot be cannulated even using t
Systemic and ~?~yoc~fr~iu~ circulatory support are not 
tnutlml!v exchrsive and have been combined espite 
dural complexity. Centrifugal pump perfusioa was em 
through the angioplasty catheter during initial clinica 
because of inadequate fl 
roller pump catheter perfusion i conjunctiou with supporte 
angioplasty. Whether systemic or ~~yocardia~ s~ ~o~ or 
combination ofthe two proves to be the preferred means of 
circlllatory assist during hi@ risk a~giop~asty remains to 
proven. It is likely that spec ific clinical situations will be k 
managed by individual supporting techniques (21). 
~~~~~v~ results. Comparison ofthe initial results of 
the Registry using cardiopulmonary support electively for 
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high risk patients with the outcome of other studies is 
difficult because there are few data on angiOP!aStY in Wiv- 
&nt high risk patients. Procedural mortality in patients 
undergoing elective angioplast), with an bjection fraction 
~35% to 40% has been reported to be approximately 3% 
(22,23). The Registry’s hospital mortality rate of 4% in the 
subgroup of patients with considerably lower ejection frac- 
tion (120%~) compares favorably with these data. Our results 
also compare favorably with the 6.9% mortality rate found in 
patients undergoing bypass urgery with an ejection fraction 
~35% (24). No data exist with which to compare our 
respective mortality rates of 0% and 7% for patients who 
were deemed surgically inoperable and those who had 
dilation of their only patent coronary vessel. The greatest 
benefit appears to have been experienced in the 40 patients 
who were considered inoperable or who had an ejection 
fraction x20%, or both, because ! here was no alternative to
this procedure. The hospital mort;:iity rate of this group was 
only 2.5%. 
Other patients did not appear !o derive signifcant benefit 
from this procedure. Seven of the eight patients who died 
were also considered candidates for bypass surgery or 
angiopiasty. There appears to be no advantage for srspported 
angiopiasty in patients with left main coronary artery steno- 
sis based on comparison of the Registry outcome with the 
procedural mortality rate of 3.9% reported by Hartzler et al. 
(22). Moreover, left main coronary artery restenosis appears 
to be a significant problem and is associated with a consid- 
erable mortality rate in patients undergoing balloon dilation 
(25). 
Postinterventional closure and later restenosis may prove 
to bt signscant problems in using circulatory support 
during balloon dilatioms pf critical lesions. In the present 
study, 7 (4%) of 173 -gess& success!u‘ullj di ated ciosed 
during hospitalization. Four of the seven patients with such 
CIOSU~~ died, confirming the critical nature of the vessels 
dilated. Contrary to previous reports, however, only three 
patients died of cardiac auses (Including one during elective 
hernia repair) during the follow-up period. With a longer 
follow-up eriod, however, increased late mortality may be 
found. Improved long-term vessel patency may have re- 
suited from the prolonged ilations employed (26). bdt this 
remains conjectural. 
Study limitations. The major limitation of the study is the 
unproved need for systemic irculatory support in all pa- 
tients meeting the suggested inclusion criteria of low ejection 
fraction Or a target vessel supplying the majority of the 
viable myocardium, or both. Many patients could have been 
nianaged with other procedures, ai:d patient selection varied 
considerably &,qong the 14 participating institutions. Al- 
though four of seven patients undergoing iate vessel occlu- 
sion died, three patients in !he Registry group had cannalas 
inserted but did not go on cardiopulmonary bypass: none of 
the three required support. At the University of Maryland 
JAW Vol. 15, No. 1 
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Hospital, six patients meeting the 
underwent coronary angiopiasty us 
approach employs arteriographic evalu 
femoral vessels, placement of 5F sheaths and cardiopu 
nary system priming. These measures allow patients t 
placed on full cardiopulmonary b pass within a few minutes 
after hemodynamic collapse. This approach lessens the risk 
of vessel injury if support is not initiated, but increases tbe 
cobt of the angiopiasty asa result of priming of the pump and 
oxygenator (currently approxima 
None of the six 
developed hemodynamic instability, and ail out 
successful. The second phase of the National 
Elective Supported Angiopiasty will i 
undergoing standby support as well as full cardio~~~mo~ary 
bypass. Clinical Irecommendations will be that patients meet- 
ing the original inclusion criteria should be ma 
standby support, whereas those undergoing dilation of their 
only patent coronary vessel or those experiencing he 
namic collapse during balloon inflation, or both, should be 
managed with prophylactic support. We have termed this 
latter critical subgroup “manifest’* risk. 
The Registry’s initial results suggest that s~~~opte~ an- 
gioplasty can be utilized in subgroups of high risk patients, 
including those with a low ejection fraction, those with only 
one patent coronary vessel and those deemed surgicaiiy 
bLioperabie, with expectation of excellent short-term out- 
come. The procedure appears to provide the greatest b 
to those without surgical or angiopllasty alternatives. 
bidity, especially in relation to cannuia placement and re- 
moval, was frequent. Because these results represent the 
initial findings of all 14 centers using this procedure, it is 
!ikely that results wlii improve with additional procedural 
and patient selection experience. Such “learning curve” 
progress was reported by Shawl et al. (27), who found both 
mortality and morbidity to decline with the performance of
additional cases. 
An additional study limitation is the differing techniques 
employed by the participating centers. The most substantial 
procedural variation was the approach to insertion and 
removal of the perfusion cannuias. Whereas percutaneous 
cannuia insertion clearly lessens the time required for initi- 
ation of cardiopulmonary b pass, percutaneous cannula 
removal is more problematic. In our group’s initial experi- 
ence, more than half nf patient morbidity was associated 
with problems at the cannuiation site. These occurred with 
approximately equal frequency in percutaneous and cut- 
down cannuia insertion. Fewer problems appear to be asso- 
ciated with percutaneous insertion and removal of 18F 
cannulas, which permit up to a 4 to 5 iiterslmin flow (27). It 
is likely that further technical refinement of the cannula 
insertion and removal procedure will take place. 
Conclusions. The Registry’s initial experience suggests 
that high risk patients with a severely depressed ejection 
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